Since MYCN amplification is strongly associated with rapid progression and poor prognosis in NB [21,22], we decided to generate drug resistance in MYCN amplified cell line derived from NB patient with a history of aggressive and metastasis (SK-N-BE(2)-C. This evidence concerns the gene MYCN and neuroblastoma.